{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:58:47Z","timestamp":1773053927270,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T00:00:00Z","timestamp":1358294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s40272-012-0006-0","type":"journal-article","created":{"date-parts":[[2013,1,15]],"date-time":"2013-01-15T09:54:56Z","timestamp":1358243696000},"page":"49-58","source":"Crossref","is-referenced-by-count":31,"title":["Counting the Cost of Meningococcal Disease"],"prefix":"10.1007","volume":"15","author":[{"given":"Claire","family":"Wright","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Wordsworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Glennie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,16]]},"reference":[{"key":"6_CR1","unstructured":"NICE. Bacterial meningitis and meningococcal septicaemia in children. Full guideline 2010. Available from URL: http:\/\/www.nice.org.uk\/nicemedia\/live\/13027\/49437\/49437.pdf . Accessed 18 Dec 2012."},{"issue":"5","key":"6_CR2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1473-3099(10)70048-7","volume":"10","author":"K Edmond","year":"2010","unstructured":"Edmond K, et al. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(5):317\u201328.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"6_CR3","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1086\/520303","volume":"26","author":"L Erickson","year":"1998","unstructured":"Erickson L, De Wals P. Complications and sequelae of meningococcal disease in Quebec, Canada, 1990\u20131994. Clin Infect Dis. 1998;26(5):1159\u201364.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"6_CR4","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.2106\/JBJS.I.01468","volume":"92","author":"F Canavese","year":"2010","unstructured":"Canavese F, Krajbich JI, LaFleur BJ. Orthopaedic sequelae of childhood meningococcemia: management considerations and outcome. J Bone Joint Surg Am. 2010;92(12):2196\u2013203.","journal-title":"J Bone Joint Surg Am"},{"issue":"Suppl 1","key":"6_CR5","doi-asserted-by":"crossref","first-page":"A54","DOI":"10.1016\/j.vaccine.2010.02.034","volume":"28","author":"AJ Hall","year":"2010","unstructured":"Hall AJ. The United Kingdom Joint Committee on Vaccination and Immunisation. Vaccine. 2010;28(Suppl 1):A54\u20137.","journal-title":"Vaccine"},{"key":"6_CR6","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/bmj.324.7341.809","volume":"324","author":"CL Trotter","year":"2002","unstructured":"Trotter CL, Edmunds WJ. Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales. BMJ. 2002;324:809.","journal-title":"BMJ"},{"key":"6_CR7","unstructured":"Scottish Intercollegiate Guidelines Network. Management of invasive meningococcal disease in children and young people. Edinburgh: Scottish Intercollegiate Guidelines Network; 2008."},{"key":"6_CR8","unstructured":"National Institute for Clinical Excellence. Guide to the methods of technology appraisal. 2004. Available from URL: http:\/\/www.nice.org.uk\/niceMedia\/pdf\/TAP_Methods.pdf . Accessed 9 Dec 2010."},{"issue":"4","key":"6_CR9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10198-009-0173-2","volume":"10","author":"Jonsson B Ten","year":"2009","unstructured":"Ten Jonsson B. Arguments for a societal perspective in the economic evaluation of medical innovations. Eur J Health Econ. 2009;10(4):357\u20139.","journal-title":"Eur J Health Econ"},{"key":"6_CR10","volume-title":"The green book: appraisal and evaluation in central government","author":"HM Treasury","year":"2003","unstructured":"Treasury HM. The green book: appraisal and evaluation in central government. London: TSO; 2003."},{"key":"6_CR11","unstructured":"Office for National Statistics. Interim life tables, 2007-2009. Available from URL: http:\/\/www.ons.gov.uk\/ons\/publications\/re-reference-tables.html?edition=tcm%3A77-61850 . Accessed 14 Dec 2010."},{"issue":"11","key":"6_CR12","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/archpedi.162.11.1036","volume":"162","author":"CM Buysse","year":"2008","unstructured":"Buysse CM, et al. Long-term health status in childhood survivors of meningococcal septic shock. Arch Pediatr Adolesc Med. 2008;162(11):1036\u201341.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"6_CR13","unstructured":"Department of Health. National schedule of reference costs 2008-09 for NHS trusts and PCTs combined. Available from URL: http:\/\/www.dh.gov.uk\/en\/Publicationsandstatistics\/Publications\/PublicationsPolicyAndGuidance\/DH_111591 . Accessed 4 Oct 2010."},{"key":"6_CR14","unstructured":"Curtis L. Unit costs of health and social care 2009. Available from URL: http:\/\/www.pssru.ac.uk\/project-pages\/unit-costs\/2009\/index.php . Accessed 21 Dec 2012."},{"key":"6_CR15","unstructured":"Holmes L, McDermid S, Sempik J. The costs of short break provision. Available from URL: http:\/\/www.ccfcs.org.uk\/Documents\/Publications\/ShortBreaksDCSF.pdf . Accessed 6 Dec 2010."},{"key":"6_CR16","unstructured":"British National Formulary, 2010. Available from URL: http:\/\/bnf.org\/bnf\/bnf\/60\/3914.htm#_3914 . Accessed 7 Dec 2010."},{"key":"6_CR17","unstructured":"British National Formulary for Children, 2010. Available from URL: http:\/\/bnfc.org\/bnfc\/bnfc\/current\/3914.htm#_3914 . Accessed 7 Dec 2010."},{"key":"6_CR18","unstructured":"Christensen H, et al. Modelling the potential impact of new menB vaccines in England allowing for herd immunity. EMGM Book of Abstracts 2011. Available from URL: http:\/\/emgm.eu\/meetings\/emgm2011\/abstracts.pdf . Accessed 21 Dec 2012."},{"issue":"9","key":"6_CR19","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2165\/00019053-200523090-00001","volume":"23","author":"R Welte","year":"2005","unstructured":"Welte R, et al. The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine. Pharmacoeconomics. 2005;23(9):855\u201374.","journal-title":"Pharmacoeconomics"},{"key":"6_CR20","unstructured":"Copps J, Heady L. What price an ordinary life? The financial costs and benefits of supporting disabled children and their families. Available from URL: http:\/\/www.philanthropycapital.org\/publications\/health\/disabled_children\/disabled_children_cost.aspx . Accessed 21 Dec 2010."},{"key":"6_CR21","unstructured":"Dobson B, Middleton S. Paying to care: the cost of childhood disability. Joseph Rowntree Foundation, 1998. Available from URL: http:\/\/www.jrf.org.uk\/publications\/paying-care-cost-childhood-disability . Accessed 21 Dec 2012."},{"key":"6_CR22","volume-title":"Disabled children in Britain: a re-analysis of the OPCS disability survey","author":"D Gordon","year":"2000","unstructured":"Gordon D, Parker R, Loughran F, Heslop P. Disabled children in Britain: a re-analysis of the OPCS disability survey. London: The Stationery Office; 2000."},{"issue":"3","key":"6_CR23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00004703-198806000-00001","volume":"9","author":"D Cadman","year":"1988","unstructured":"Cadman D, Boyle M, Offord DR. The Ontario Child Health Study: social adjustment and mental health of siblings of children with chronic health problems. J Dev Behav Pediatr. 1988;9(3):117\u201321.","journal-title":"J Dev Behav Pediatr"},{"issue":"9","key":"6_CR24","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S1474-4422(12)70180-1","volume":"11","author":"RM Viner","year":"2012","unstructured":"Viner RM, et al. Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study. Lancet Neurol. 2012;11(9):774\u201383.","journal-title":"Lancet Neurol"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-012-0006-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-012-0006-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-012-0006-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:44:43Z","timestamp":1559490283000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-012-0006-0"}},"subtitle":["Scenarios of Severe Meningitis and Septicemia"],"short-title":[],"issued":{"date-parts":[[2013,1,16]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["6"],"URL":"https:\/\/doi.org\/10.1007\/s40272-012-0006-0","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,16]]}}}